Alkermes (ALKS) Tops Q1 EPS by 5c

Alkermes (NASDAQ: ALKS) reported Q1 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $223.1 million versus the consensus estimate of $216.99 million.

For earnings history and earnings-related data on Alkermes (ALKS) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c
• Paramount Global (PARA) Tops Q2 EPS by 480c